J PINEAL RES 润色咨询

JOURNAL OF PINEAL RESEARCH

出版年份:1984 年文章数:1257 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:25.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2022-12-14 769023184 来自湖北省

    under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?

    9

    展开9条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2022-08-05 白.

    请问WB的原始数据要不要未裁剪的膜

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2022-07-21 ms2000001196837930

    2021
    JOURNAL IMPACT FACTOR:12.081
    JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2022-07-21 ms2000001196837930

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。
    换主编后,目前杂志自引率在6%。
    说杂志水的,自己先能去发一篇吧!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-03-10 小小心

    投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    上传文章有什么要求?

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    如何判断两种药物之间是协同作用还是相加作用?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-06-19 ms4291550837728708

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:眼部新生血管
    经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-03-28 zhizhuo执念

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:难免投机取巧者,也罢,亦如此

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了,不知道是不是外审了,有大神能给个投稿过程吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 <br>JOURNAL IMPACT FACTOR:12.081<br>JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS:11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:对于我们这些非关系户,能中,就是运气+实力。录用论文实验数据量大,属于博士学位的大部分内容。<br>换主编后,目前杂志自引率在6%。<br>说杂志水的,自己先能去发一篇吧!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review,我看wiley杂志不送审也会显示under review状态,求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974781, encodeId=6f829e47817d, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:眼部新生血管<br>经验分享:课题组在这个杂志中过几篇文章。但还是觉得这个杂志很神奇,文章水平层次不齐。我们组投稿,数据量很多,秒拒。。。数据量很少,editor反到觉得很有兴趣。关键是对editor的胃口。当然如果文章拉了主编一起发的,比较容易,那个数据量更少了。。但是至少我们是不认识编委的。总的来说,对我们们这些非关系户,能中需要运气+实力。中不了,那也没什么,换个杂志而已。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66161826681, createdName=ms4291550837728708, createdTime=Sat Jun 19 03:32:10 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951845, encodeId=5c8d95184516, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:难免投机取巧者,也罢,亦如此, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:57:37 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951844, encodeId=73ed95184438, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d48c1612835, createdName=zhizhuo执念, createdTime=Sun Mar 28 13:56:26 CST 2021, time=2021-03-28, status=1, ipAttribution=)]
    2021-03-28 zhizhuo执念

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:杂志还是很难投中,不免有些主编挂名文章是这样上位的,另外有些文章看似水平一般,但却有创新或者别出心裁的角度来阐述某一问题,水平还是值得的,各位大神都加油!

    0

共174条页码: 1/18页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分